精优药业(00858)：郭懿获委任为行政总裁
EXTRAWELL PHAREXTRAWELL PHAR(HK:00858) 智通财经网·2025-12-30 12:16

Core Viewpoint - The company, 精优药业 (00858), announced a leadership change aimed at enhancing corporate governance and meeting development needs, effective January 1, 2026 [1] Group 1 - Dr. 谢毅 will resign as CEO to focus on formulating company strategy, while continuing as Chairman of the Board and Executive Director [1] - Dr. 郭懿 will be appointed as the new CEO [1]